Literature DB >> 15557223

Replication, recombination and packaging of amplicon DNA in cells infected with the herpes simplex virus type 1 alkaline nuclease null mutant ambUL12.

Iain M Porter1, Nigel D Stow1.   

Abstract

The alkaline nuclease (AN) encoded by gene UL12 of herpes simplex virus type 1 (HSV-1) is essential for efficient virus replication but its role during the lytic cycle remains incompletely understood. Inactivation of the UL12 gene results in reductions in viral DNA synthesis, DNA packaging, egress of DNA-containing capsids from the nucleus and ability of progeny virions to initiate new cycles of infection. Mechanistically, AN has been implicated in resolving branched structures in HSV-1 replicative intermediates prior to encapsidation, and promoting DNA strand-exchange. In this study, amplicons (bacterial plasmids containing functional copies of a virus replication origin and packaging signal) were used to analyse further the defects of the UL12 null mutant ambUL12. When ambUL12 was used as a helper virus both replication and packaging of the transfected amplicon were reduced in comparison with cells infected with wild-type (wt) HSV-1, and to extents similar to those previously observed for genomic ambUL12 DNA. By using amplicons differing at a specific restriction endonuclease site it was demonstrated that replicating molecules exhibit high frequency intermolecular recombination in both wt- and mutant-infected cells. Surprisingly, in the absence of the UL12 product, amplicons lacking a functional encapsidation signal were packaged. Moreover, these packaged molecules could be serially propagated indicating that they had been incorporated into functional virions. This difference in packaging specificity between wt HSV-1 and ambUL12 might indicate that replicative intermediates accumulating in the absence of AN contain an increased incidence of structures that can serve for the initiation of DNA packaging.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557223     DOI: 10.1099/vir.0.80403-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  The Exonuclease Activity of Herpes Simplex Virus 1 UL12 Is Required for Production of Viral DNA That Can Be Packaged To Produce Infectious Virus.

Authors:  Lorry M Grady; Renata Szczepaniak; Ryan P Murelli; Takeshi Masaoka; Stuart F J Le Grice; Dennis L Wright; Sandra K Weller
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98.

Authors:  Alison L Kuchta; Hardik Parikh; Yali Zhu; Glen E Kellogg; Deborah S Parris; Michael A McVoy
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

3.  Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.

Authors:  Eliza Tsitoura; Alberto L Epstein
Journal:  Open Virol J       Date:  2010-06-18

4.  Conserved residues in the UL24 protein of herpes simplex virus 1 are important for dispersal of the nucleolar protein nucleolin.

Authors:  Luc Bertrand; Gabriel André Leiva-Torres; Huda Hyjazie; Angela Pearson
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  The UL15 protein of herpes simplex virus type 1 is necessary for the localization of the UL28 and UL33 proteins to viral DNA replication centres.

Authors:  Martin R Higgs; Valerie G Preston; Nigel D Stow
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

6.  Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures.

Authors:  C-Y Hsiang; T-Y Ho
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

7.  Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.

Authors:  Zohaib Alam; Zainab Al-Mahdi; Yali Zhu; Zachary McKee; Deborah S Parris; Hardik I Parikh; Glen E Kellogg; Alison Kuchta; Michael A McVoy
Journal:  Antiviral Res       Date:  2014-12-10       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.